[1. Bristow, R. G., & Hill, R. P. (2008). Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer, 8, 180-192.10.1038/nrc2344]Search in Google Scholar
[2. Zhang, J., Cao, J., Ma, S., Dong, R., Meng, W., Ying, M., Weng, Q., Chen, Z., Ma, J., Fang, Q., He, Q., & Yang, B. (2014). Tumor hypoxia enhances non-small cell lung cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling. Oncotarget, 5(20), 9664-9677.10.18632/oncotarget.1856]Search in Google Scholar
[3. Ackerman, D., & Simon, M. C. (2014). Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell. Biol., 24(8), 472-477.10.1016/j.tcb.2014.06.001]Search in Google Scholar
[4. Brown, J. M. (2007). Tumor hypoxia in cancer therapy. H. Sies, & B. Brune (Eds.) Methods in enzymolology. Vol. 435 (pp. 297-321). Academic Press.10.1016/S0076-6879(07)35015-5]Search in Google Scholar
[5. Nagelkerke, A., Bussink, J., Mujcic, H., Wouters, B. G., Lehmann, S., Sweep, F. C. G. J., & Span, P. N. (2013). Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response. Breast Cancer Res., 15, R2(13pp).10.1186/bcr3373]Search in Google Scholar
[6. Weeks, A. J., Paul, R. L., Marsden, P. K., Blower, P. J., & Lloyd, D. R. (2010). Radiobiological effects of hypoxia dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells. Eur. J. Nucl. Med. Mol. Imaging, 37, 330-338.10.1007/s00259-009-1305-8]Search in Google Scholar
[7. Mees, G., Dierckx, R., Vangestel, Ch., & Van de Wiele, Ch. (2009). Molecular imaging of hypoxia with radiolabelled agents. Eur. J. Nucl. Med. Mol. Imaging, 36, 1675-1680.10.1007/s00259-009-1195-9]Search in Google Scholar
[8. Peeters, S. G., Zegers, C. M., Lieuwes, N. G., van Elmpt, W., Eriksson, J., van Dongen, G. A., Dubois, L., & Lambin, P. (2015). A comparative study of the hypoxia PET tracers [18F]HX4, [18F]FAZA, and [18F]FMISO in a preclinical tumor model. Int. J. Radiat. Oncol. Biol. Phys. 1, 91(2), 351-359.10.1016/j.ijrobp.2014.09.045]Search in Google Scholar
[9. Lin, A., & Hahn, S. M. (2012). Hypoxia imaging markers and applications for radiation treatment planning. Semin. Nucl. Med., 42, 343-352.10.1053/j.semnuclmed.2012.04.002]Search in Google Scholar
[10. Campanile, C., Arlt, M. J. E., Krämer, S. D., Honer, M., Gvozdenovic, A., Brennecke, P., Fischer, C. A., Sabile, A. A., Müller, A., Ametamey, S. A., Born, W., Schibli, R., & Fuchs, B. (2013). Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models. J. Nucl. Med., 54(8), 1362-1368.10.2967/jnumed.112.115527]Search in Google Scholar
[11. Thézé, B., Bernards, N., Beynel, A., Bouet, S., Kuhnast, B., Buvat, I., Tavitian, B., & Boisgard, R. (2015). Monitoring therapeutic effi cacy of sunitinib using [18F]FDG and [18F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma. BMC Cancer, 15, 534(10pp).10.1186/s12885-015-1540-2]Search in Google Scholar
[12. Arvold, N. D., Heidari, P., Kunawudhi, A., Sequist, L. V., & Mahmood, U. (2015). Tumor hypoxia response after targeted therapy in EGFR-mutant non-small cell lung cancer. Technol. Cancer Res. Treat., 15(2), 234-242.10.1177/1533034615574386]Search in Google Scholar
[13. Bruehlmeier, M., Kaser-Hotz, B., Achermann, R., Rohrer Bley, C., Wergin, M., Schubiger, P. A., & Ametamey, S. M. (2005). Measurement of tumor hypoxia in spontaneous canine sarcomas. Vet. Radiol. Ultrasoun., 46(4), 348-354.10.1111/j.1740-8261.2005.00065.x]Search in Google Scholar
[14. Kilian, K., Chabecki, B., Kiec, J., Kunka, A., Panas, B., Wójcik, M., & Pekal, A. (2014). Synthesis, quality control and determination of metallic impurities in 18F-fl udeoxyglucose production process. Rep. Pract. Oncol. Radiother., 19, 22-31.10.1016/j.rpor.2014.03.001]Search in Google Scholar
[15. Anzellotti, A., Bailey, J., Ferguson, D., McFarland, A., Bochev, P., Andreev, G., Awasthi, V., & Brown- -Proctor, C. (2015). Automated production and quality testing of [18F]labeled radiotracers using the BG75 system. J. Radioanal. Nucl. Chem., 305(2), 387-401.10.1007/s10967-015-4045-1]Search in Google Scholar
[16. Blom, E., & Koziorowski, J. (2014). Automated synthesis of [18F]FMISO on IBA Synthera®. J. Radioanal. Nucl. Chem., 299(1), 265-270.10.1007/s10967-013-2753-y]Search in Google Scholar
[17. Nandy, S. K., & Rajan, M. (2010). Fully automated radiosynthesis of [18F]Fluoromisonidazole with single neutral alumina column purifi cation: optimization of reaction parameters. J. Radioanal. Nucl. Chem., 286(1), 241-248.10.1007/s10967-010-0644-z]Search in Google Scholar
[18. Bowen, S. R., van der Kogel, A. J., Nordsmark, M., Bentzen, M. S., & Jeraj, R. (2011). Characterization of PET hypoxia tracer uptake and tissue oxygenation via electrochemical modeling. Nucl. Med. Biol., 38(6), 771-780.10.1016/j.nucmedbio.2011.02.002]Search in Google Scholar